橄榄苦苷减缓奥氮平诱导肝脏糖代谢紊乱的研究
摘要
关键词
全文:
PDF参考
[1]PENG S,LI W,LYU L,et al. BDNF as a biomarker in diagnosis and evaluation of treatment for schizophrenia and depression[J]. Discov Med,2018,26( 143) : 127-136.[2]WALKER E R,MCGEE R E,DRUSS B G. Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis[J]. JAMA Psychiatry, 2015,72( 4) : 334-341.[3]ROJO LE, GASPAR PA, SILVA H, et al. Metabolic syndrome and obesity among users of second generation antipsychotics: a global challenge for modern psychopharmacology [J]. Pharmacol Res, 2015, 101: 74-85.[4]戴欣怡,朱锦峰,韦善屹,等.药用植物裂环烯醚萜苷类化合物生物合成途径关键酶基因研究进展[J].西北植物学报,2023,43(03):527-538.[5]郑洁,魏鉴腾,刘建飞,等.油橄榄叶提取物生物活性研究进展[J].中国中药杂志,2016,41(4):613-618.[6]邹称林.奥氮平在精神分裂症患者治疗中的疗效及患者体质指数、血浆瘦素及下丘脑神经激素水平观察[J].微量元素与健康研究,2023,40(01):94-95.[7]郭东浩,韩宇博,张美君,等.血尿酸水平和稳态模型胰岛素抵抗指数对代谢综合征患者新发心房颤动的影响及预测价值[J].中国医药,2023,18(02):187-191.[8]衡荣,罗锐,冯杰,冷珂.齐拉西酮与奥氮平对首发精神分裂症患者糖脂代谢、认知功能的影响及可能作用机制分析[J].国际精神病学杂志,2018,45(04):594-596+603.
DOI: http://dx.doi.org/10.12361/2661-3603-05-13-133993
Refbacks
- 当前没有refback。